Please enable JavaScript to continue using this application.

Compare $RIGL vs $SANA | Chartloom

Compare

$RIGL vs $SANA

Rigel Pharmaceuticals Inc · Sana Biotechnology Inc

RIGL

Rigel Pharmaceuticals Inc

SANA

Sana Biotechnology Inc

Compare $RIGL vs $SANA

Comparing Rigel Pharmaceuticals Inc and Sana Biotechnology Inc

RIGLRigel Pharmaceuticals Inc

SANASana Biotechnology Inc

RIGLRigel Pharmaceuticals Inc

Market cap

$908M

P/E (TTM)

2.98x

Forward P/E (NTM)

15.85x

Forward P/S (NTM)

2.61x

Rev growth (TTM)

3.3%

YTD performance

17.3%

52W performance

70.7%

FCF yield

1.0%

SANASana Biotechnology Inc

Market cap

$776M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-33.4%

52W performance

-38.4%

FCF yield

-17.4%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

RIGL

SANA

Detailed metrics comparison

RIGL

Rigel Pharmaceuticals Inc

SANA

Sana Biotechnology Inc

Market Cap

RIGL$908M

SANA$776M

Enterprise Value

RIGL$886M

SANA$719M

Price

RIGL$49.08

SANA$2.79

P/E Ratio

RIGL2.98x

SANAN/A

P/S Ratio

RIGL3.28x

SANA0.00x

EV/Sales

RIGL3.20x

SANA0.00x

EV/EBITDA

RIGL9.50x

SANA0.00x

P/B Ratio

RIGL2.07x

SANA5.60x

P/FCF Ratio

RIGL100.69x

SANAN/A

EV/FCF

RIGL98.29x

SANA-5.33x

PEG Ratio

RIGL0.01x

SANAN/A

Forward P/E (NTM)

RIGL15.85x

SANAN/A

Forward P/S (NTM)

RIGL2.61x

SANAN/A

Revenue (TTM)

RIGL$277M

SANA$0

Revenue Growth (YoY)

RIGL3.3%

SANAN/A

Forward Rev Growth

RIGL21.9%

SANA427.6%

Gross Margin (TTM)

RIGL91.4%

SANA0.0%

Operating Margin (TTM)

RIGL31.4%

SANA0.0%

EBITDA Margin (TTM)

RIGL32.4%

SANA0.0%

Net Margin (TTM)

RIGL116.3%

SANA0.0%

FCF Margin (TTM)

RIGL3.3%

SANAN/A

Net Income (TTM)

RIGL$322M

SANA$-212M

FCF (TTM)

RIGL$9M

SANA$-135M

EPS (TTM)

RIGL$16.45

SANA-$0.72

ROE (TTM)

RIGL96.5%

SANA-13449.0%

ROA (TTM)

RIGL72.3%

SANA-5112.0%

ROIC (TTM)

RIGL84.1%

SANA-13449.0%

Cash

RIGL$61M

SANA$57M

Debt

RIGL$39M

SANA$0

Net Cash/Debt

RIGL$22M

SANA$57M

Current Ratio (TTM)

RIGL1.94x

SANA1.38x

Quick Ratio (TTM)

RIGL1.58x

SANA1.33x

Debt/Equity (TTM)

RIGL0.09x

SANA0.00x

Debt/Assets (TTM)

RIGL0.0%

SANA0.0%

Interest Coverage (TTM)

RIGLN/A

SANAN/A

Net Debt/EBITDA (TTM)

RIGL0.00x

SANA0.00x

Beta

RIGL1.26

SANA2.31

52W Performance

RIGL70.7%

SANA-38.4%

YTD Performance

RIGL17.3%

SANA-33.4%

% from 52W High

RIGL-6.0%

SANA-57.4%

% from 52W Low

RIGL96.7%

SANA6.9%

Asset Turnover (TTM)

RIGL0.62x

SANA0.00x

FCF Yield (TTM)

RIGL1.0%

SANA-17.4%

Earnings Yield (TTM)

RIGL35.5%

SANA-27.3%

Dividend Yield (TTM)

RIGLN/A

SANAN/A

Rule of 40

RIGL6.6

SANA0.0

EV/GP/RG

RIGL0.13

SANAN/A

Ticker research

View RIGL research View SANA research

Metric	RIGL Rigel Pharmaceuticals Inc	SANA Sana Biotechnology Inc
Market & Valuation
Market Cap	$908M	$776M
Enterprise Value	$886M	$719M
Price	$49.08	$2.79
P/E Ratio	2.98x	N/A
P/S Ratio	3.28x	0.00x
EV/Sales	3.20x	0.00x
EV/EBITDA	9.50x	0.00x
P/B Ratio	2.07x	5.60x
P/FCF Ratio	100.69x	N/A
EV/FCF	98.29x	-5.33x
PEG Ratio	0.01x	N/A
Forward P/E (NTM)	15.85x	N/A
Forward P/S (NTM)	2.61x	N/A
Revenue & Growth
Revenue (TTM)	$277M	$0
Revenue Growth (YoY)	3.3%	N/A
Forward Rev Growth	21.9%	427.6%
Profitability
Gross Margin (TTM)	91.4%	0.0%
Operating Margin (TTM)	31.4%	0.0%
EBITDA Margin (TTM)	32.4%	0.0%
Net Margin (TTM)	116.3%	0.0%
FCF Margin (TTM)	3.3%	N/A
Net Income (TTM)	$322M	$-212M
FCF (TTM)	$9M	$-135M
EPS (TTM)	$16.45	-$0.72
ROE (TTM)	96.5%	-13449.0%
ROA (TTM)	72.3%	-5112.0%
ROIC (TTM)	84.1%	-13449.0%
Financial Health
Cash	$61M	$57M
Debt	$39M	$0
Net Cash/Debt	$22M	$57M
Current Ratio (TTM)	1.94x	1.38x
Quick Ratio (TTM)	1.58x	1.33x
Debt/Equity (TTM)	0.09x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.26	2.31
52W Performance	70.7%	-38.4%
YTD Performance	17.3%	-33.4%
% from 52W High	-6.0%	-57.4%
% from 52W Low	96.7%	6.9%
Efficiency & Yields
Asset Turnover (TTM)	0.62x	0.00x
FCF Yield (TTM)	1.0%	-17.4%
Earnings Yield (TTM)	35.5%	-27.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	6.6	0.0
EV/GP/RG	0.13	N/A
Ticker research	View RIGL research	View SANA research

Valuation

P/E Ratio

RIGL

2.98x

P/S Ratio

SANA

0.00x

RIGL

3.28x

EV/FCF

SANA

-5.33x

RIGL

98.29x

Growth & revenue

Revenue Growth TTM

RIGL

3.3%

Forward Revenue Growth

SANA

427.6%

RIGL

21.9%

Profitability & performance

Gross Margin

RIGL

91.4%

SANA

0.0%

ROE

RIGL

96.5%

SANA

-13449.0%

FCF Yield %

RIGL

1.0%

SANA

-17.4%

52-Week Performance

RIGL

70.7%

SANA

-38.4%

Detailed metrics comparison

RIGL

Rigel Pharmaceuticals Inc

SANA

Sana Biotechnology Inc

Market Cap

RIGL$908M

SANA$776M

Enterprise Value

RIGL$886M

SANA$719M

Price

RIGL$49.08

SANA$2.79

P/E Ratio

RIGL2.98x

SANAN/A

P/S Ratio

RIGL3.28x

SANA0.00x

EV/Sales

RIGL3.20x

SANA0.00x

EV/EBITDA

RIGL9.50x

SANA0.00x

P/B Ratio

RIGL2.07x

SANA5.60x

P/FCF Ratio

RIGL100.69x

SANAN/A

EV/FCF

RIGL98.29x

SANA-5.33x

PEG Ratio

RIGL0.01x

SANAN/A

Forward P/E (NTM)

RIGL15.85x

SANAN/A

Forward P/S (NTM)

RIGL2.61x

SANAN/A

Revenue (TTM)

RIGL$277M

SANA$0

Revenue Growth (YoY)

RIGL3.3%

SANAN/A

Forward Rev Growth

RIGL21.9%

SANA427.6%

Gross Margin (TTM)

RIGL91.4%

SANA0.0%

Operating Margin (TTM)

RIGL31.4%

SANA0.0%

EBITDA Margin (TTM)

RIGL32.4%

SANA0.0%

Net Margin (TTM)

RIGL116.3%

SANA0.0%

FCF Margin (TTM)

RIGL3.3%

SANAN/A

Net Income (TTM)

RIGL$322M

SANA$-212M

FCF (TTM)

RIGL$9M

SANA$-135M

EPS (TTM)

RIGL$16.45

SANA-$0.72

ROE (TTM)

RIGL96.5%

SANA-13449.0%

ROA (TTM)

RIGL72.3%

SANA-5112.0%

ROIC (TTM)

RIGL84.1%

SANA-13449.0%

Cash

RIGL$61M

SANA$57M

Debt

RIGL$39M

SANA$0

Net Cash/Debt

RIGL$22M

SANA$57M

Current Ratio (TTM)

RIGL1.94x

SANA1.38x

Quick Ratio (TTM)

RIGL1.58x

SANA1.33x

Debt/Equity (TTM)

RIGL0.09x

SANA0.00x

Debt/Assets (TTM)

RIGL0.0%

SANA0.0%

Interest Coverage (TTM)

RIGLN/A

SANAN/A

Net Debt/EBITDA (TTM)

RIGL0.00x

SANA0.00x

Beta

RIGL1.26

SANA2.31

52W Performance

RIGL70.7%

SANA-38.4%

YTD Performance

RIGL17.3%

SANA-33.4%

% from 52W High

RIGL-6.0%

SANA-57.4%

% from 52W Low

RIGL96.7%

SANA6.9%

Asset Turnover (TTM)

RIGL0.62x

SANA0.00x

FCF Yield (TTM)

RIGL1.0%

SANA-17.4%

Earnings Yield (TTM)

RIGL35.5%

SANA-27.3%

Dividend Yield (TTM)

RIGLN/A

SANAN/A

Rule of 40

RIGL6.6

SANA0.0

EV/GP/RG

RIGL0.13

SANAN/A

Ticker research

View RIGL research View SANA research

Metric	RIGL Rigel Pharmaceuticals Inc	SANA Sana Biotechnology Inc
Market & Valuation
Market Cap	$908M	$776M
Enterprise Value	$886M	$719M
Price	$49.08	$2.79
P/E Ratio	2.98x	N/A
P/S Ratio	3.28x	0.00x
EV/Sales	3.20x	0.00x
EV/EBITDA	9.50x	0.00x
P/B Ratio	2.07x	5.60x
P/FCF Ratio	100.69x	N/A
EV/FCF	98.29x	-5.33x
PEG Ratio	0.01x	N/A
Forward P/E (NTM)	15.85x	N/A
Forward P/S (NTM)	2.61x	N/A
Revenue & Growth
Revenue (TTM)	$277M	$0
Revenue Growth (YoY)	3.3%	N/A
Forward Rev Growth	21.9%	427.6%
Profitability
Gross Margin (TTM)	91.4%	0.0%
Operating Margin (TTM)	31.4%	0.0%
EBITDA Margin (TTM)	32.4%	0.0%
Net Margin (TTM)	116.3%	0.0%
FCF Margin (TTM)	3.3%	N/A
Net Income (TTM)	$322M	$-212M
FCF (TTM)	$9M	$-135M
EPS (TTM)	$16.45	-$0.72
ROE (TTM)	96.5%	-13449.0%
ROA (TTM)	72.3%	-5112.0%
ROIC (TTM)	84.1%	-13449.0%
Financial Health
Cash	$61M	$57M
Debt	$39M	$0
Net Cash/Debt	$22M	$57M
Current Ratio (TTM)	1.94x	1.38x
Quick Ratio (TTM)	1.58x	1.33x
Debt/Equity (TTM)	0.09x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.26	2.31
52W Performance	70.7%	-38.4%
YTD Performance	17.3%	-33.4%
% from 52W High	-6.0%	-57.4%
% from 52W Low	96.7%	6.9%
Efficiency & Yields
Asset Turnover (TTM)	0.62x	0.00x
FCF Yield (TTM)	1.0%	-17.4%
Earnings Yield (TTM)	35.5%	-27.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	6.6	0.0
EV/GP/RG	0.13	N/A
Ticker research	View RIGL research	View SANA research